Intervention

AVM0703

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting0

Common conditions17

Lead sponsors shown1

Clinical trials

1 shown

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsNCT05974410

AVAILABLE

Common conditions

Acute Leukemia1 Breast Cancer1 Cancer1 Desmoplastic Round Cell Sarcoma1 Esophageal Andeocarcinoma1 Gastric Cancer1 Glioblastoma1 Hodgkin Lymphoma1 Mixed Phenotype AML1 Non-hodgkin Lymphoma1 Ovarian Cancer1 Pancreatic Cancer1 Prostate Cancer1 Spindle Cell Sarcoma1 Squamous Cell Carcinoma1 Tumor, Brain1 Tumor, Solid1

Leading sponsors

AVM Biotechnology Inc1

Trial status mix

AVAILABLE1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.